Zhu XZ - Search Results

1

Subtyping-based platform guides precision medicine for heavily pretreated metastatic triple-negative breast cancer: The FUTURE phase II umbrella clinical trial.

Liu Y, Zhu XZ, Xiao Y, Wu SY, Zuo WJ, Yu Q, Cao AY, Li JJ, Yu KD, Liu GY, Wu J, Sun T, Cui JW, Lv Z, Li HP, Zhu XY, Jiang YZ, Wang ZH, Shao ZM. Liu Y, et al. Among authors: zhu xy, zhu xz. Cell Res. 2023 May;33(5):389-402. doi: 10.1038/s41422-023-00795-2. Epub 2023 Mar 27. Cell Res. 2023. PMID: 36973538 Free PMC article. Clinical Trial.

2

The prognostic and predictive potential of Ki-67 in triple-negative breast cancer.

Zhu X, Chen L, Huang B, Wang Y, Ji L, Wu J, Di G, Liu G, Yu K, Shao Z, Wang Z. Zhu X, et al. Sci Rep. 2020 Jan 14;10(1):225. doi: 10.1038/s41598-019-57094-3. Sci Rep. 2020. PMID: 31937819 Free PMC article.

3

A Prognostic Model for Breast Cancer With Liver Metastasis.

Ji L, Fan L, Zhu X, Gao Y, Wang Z. Ji L, et al. Front Oncol. 2020 Sep 2;10:1342. doi: 10.3389/fonc.2020.01342. eCollection 2020. Front Oncol. 2020. PMID: 33014776 Free PMC article.

4

Risk and prognostic factors of breast cancer with liver metastases.

Ji L, Cheng L, Zhu X, Gao Y, Fan L, Wang Z. Ji L, et al. BMC Cancer. 2021 Mar 6;21(1):238. doi: 10.1186/s12885-021-07968-5. BMC Cancer. 2021. PMID: 33676449 Free PMC article.

5

Efficacy and mechanism of the combination of PARP and CDK4/6 inhibitors in the treatment of triple-negative breast cancer.

Zhu X, Chen L, Huang B, Li X, Yang L, Hu X, Jiang Y, Shao Z, Wang Z. Zhu X, et al. J Exp Clin Cancer Res. 2021 Apr 8;40(1):122. doi: 10.1186/s13046-021-01930-w. J Exp Clin Cancer Res. 2021. PMID: 33832512 Free PMC article.

6

High Expression of microRNA-223 Indicates a Good Prognosis in Triple-Negative Breast Cancer.

Chen L, Zhu X, Han B, Ji L, Yao L, Wang Z. Chen L, et al. Front Oncol. 2021 Apr 13;11:630432. doi: 10.3389/fonc.2021.630432. eCollection 2021. Front Oncol. 2021. PMID: 33928027 Free PMC article.

7

Prognostic Score for De Novo Metastatic Breast Cancer With Liver Metastasis and Its Predictive Value of Locoregional Treatment Benefit.

Ji L, Fan L, Zhu X, Gao Y, Wang Z. Ji L, et al. Front Oncol. 2021 Aug 27;11:651636. doi: 10.3389/fonc.2021.651636. eCollection 2021. Front Oncol. 2021. PMID: 34513662 Free PMC article.

8

Single-cell morphological and topological atlas reveals the ecosystem diversity of human breast cancer.

Zhao S, Chen DP, Fu T, Yang JC, Ma D, Zhu XZ, Wang XX, Jiao YP, Jin X, Xiao Y, Xiao WX, Zhang HY, Lv H, Madabhushi A, Yang WT, Jiang YZ, Xu J, Shao ZM. Zhao S, et al. Among authors: zhu xz. Nat Commun. 2023 Oct 25;14(1):6796. doi: 10.1038/s41467-023-42504-y. Nat Commun. 2023. PMID: 37880211 Free PMC article.

9

Stability and variability of molecular subtypes: comparative analysis of primary and metastatic triple-negative breast cancer.

Zhu X, Ying X, Liu Y, Wang Y, Chen L, Shao Z, Jin X, Jiang Y, Wang Z. Zhu X, et al. Cancer Biol Med. 2024 May 16;21(9):784-98. doi: 10.20892/j.issn.2095-3941.2024.0009. Cancer Biol Med. 2024. PMID: 38752685 Free PMC article.

10

Clinicopathological Characteristics and Survival Outcomes of Mammary Paget's Disease: A Retrospective Study Based on a Chinese Population.

Han BY, Xu XL, Zhu XZ, Han XC, Hu X, Ling H. Han BY, et al. Among authors: zhu xz. Cancer Manag Res. 2022 Jan 18;14:237-247. doi: 10.2147/CMAR.S338788. eCollection 2022. Cancer Manag Res. 2022. PMID: 35125891 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

383 results

Search Page

Filters